EVEROLIMUS-BASED IMMUNOSUPPRESSION PROVIDES SUPERIOR RENAL FUNCTION AND COMPARABLE EFFICACY VERSUS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMISED CONTROLLED TRIAL

被引：1

作者：

Nevens, F. ^{[1
]}

De Carlis, L. ^{[2
]}

Metselaar, H. J. ^{[3
]}

Kaiser, G. M. ^{[4
]}

Saliba, F. ^{[5
]}

Jonas, S. ^{[6
]}

Duvoux, C. ^{[7
]}

Dong, G. ^{[8
]}

Junge, G. ^{[9
]}

Lopez, P. ^{[9
]}

De Simone, P. ^{[10
]}

机构：

[1] UZ Leuven, Louvain, Belgium

[2] Osped Niguarda Ca Granda, Milan, Italy

[3] Univ Rotterdam Hosp, Erasmus MC, Rotterdam, Netherlands

[4] Univ Klinikum Essen, Essen, Germany

[5] Hop Paul Brousse, Villejuif, France

[6] Univ Med Ctr Leipzig, Leipzig, Germany

[7] Hop Henri Mondor, F-94010 Creteil, France

[8] Novartis Pharmaceut, E Hanover, NJ USA

[9] Novartis Pharma AG, Basel, Switzerland

[10] Azienda Osped Univ Pisana, Pisa, Italy

来源：

关键词：

D O I：

10.1016/S0168-8278(13)60028-8

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：S12 / S12

页数：1